3M vs Kimberly-Clark
Global industrial conglomerate spanning safety consumer and healthcare products vs Global maker of tissue and personal care products. Which is the better buy for your portfolio in July 2026? Plain-English answer below.
3M has spent years unwinding a diversified industrial conglomerate to sharpen its focus, while Kimberly-Clark runs a tighter consumer staples ship built around tissue, hygiene, and personal care products sold in virtually every global market. Both companies generate enormous free cash flow and have sustained long dividend track records, making them fixtures in income-oriented portfolios. The 3M vs Kimberly-Clark comparison examines how litigation overhang, portfolio transformation, organic volume growth, and pricing power stack up when you pit a restructuring industrial against a steady consumer staples compounder.
3M has spent years unwinding a diversified industrial conglomerate to sharpen its focus, while Kimberly-Clark runs a tighter consumer staples ship built around tissue, hygiene, and personal care produ...
Why It’s Moving
3M is trading in a cautious analyst zone as Wall Street waits for a clearer catalyst.
- Analyst sentiment on 3M remains mixed but broadly cautious, with consensus readings clustering around Hold and only modest upside to most target ranges, suggesting the market is still waiting for clearer proof of sustained improvement.
- Recent analyst updates in late June and June 10 included target adjustments rather than major rating shifts, indicating investors are reacting more to incremental valuation changes than to a new catalyst.
- The wider setup for MMM appears driven by the gap between current trading levels and analyst targets, which keeps the stock in a wait-and-see zone unless earnings, margins, or guidance deliver a stronger surprise.
KMB’s upside case hinges on whether cost cuts can outweigh softer sales and margin pressure.
- Analysts are still pointing to mixed momentum: softer North America sales and cost pressure are weighing on the near-term setup, even as investors watch for benefits from ongoing portfolio cleanup and efficiency efforts.
- The stock is being framed around a broader improvement story, with analysts focusing on whether divestitures and cost synergies can offset weak category trends and input-cost uncertainty.
- Recent analyst views remain mostly cautious, which makes any upside case depend less on a single catalyst and more on evidence that margin discipline and business transformation are starting to show through.
3M is trading in a cautious analyst zone as Wall Street waits for a clearer catalyst.
- Analyst sentiment on 3M remains mixed but broadly cautious, with consensus readings clustering around Hold and only modest upside to most target ranges, suggesting the market is still waiting for clearer proof of sustained improvement.
- Recent analyst updates in late June and June 10 included target adjustments rather than major rating shifts, indicating investors are reacting more to incremental valuation changes than to a new catalyst.
- The wider setup for MMM appears driven by the gap between current trading levels and analyst targets, which keeps the stock in a wait-and-see zone unless earnings, margins, or guidance deliver a stronger surprise.
KMB’s upside case hinges on whether cost cuts can outweigh softer sales and margin pressure.
- Analysts are still pointing to mixed momentum: softer North America sales and cost pressure are weighing on the near-term setup, even as investors watch for benefits from ongoing portfolio cleanup and efficiency efforts.
- The stock is being framed around a broader improvement story, with analysts focusing on whether divestitures and cost synergies can offset weak category trends and input-cost uncertainty.
- Recent analyst views remain mostly cautious, which makes any upside case depend less on a single catalyst and more on evidence that margin discipline and business transformation are starting to show through.
Investment Analysis
3M
MMM
Pros
- 3M has raised its 2025 adjusted earnings forecast, indicating confidence in profit growth and operational improvements under new management.
- The company demonstrated strong Q3 earnings with revenue and EPS beating analyst estimates, supporting positive momentum.
- 3M is undergoing successful restructuring and cost-saving initiatives, which are improving operating margins and future growth prospects.
Considerations
- 3M’s valuation ranks low on undervaluation metrics, indicating potential risks in price appreciation beyond recent gains.
- The stock has faced multiple years of legal challenges, which continue to present execution and financial risks despite recent settlements.
- 3M operates in cyclical industrial sectors, making it sensitive to economic downturns and commodity price fluctuations.
Pros
- Kimberly-Clark is focusing on consumer-health product leadership through strategic initiatives and AI collaborations to boost innovation.
- The company has a stable dividend growth history and is merging with Kenvue, aiming to enhance scale and market presence in consumer products.
- Kimberly-Clark maintains a solid market position in personal care and hygiene segments globally, supported by its diverse geographic footprint.
Considerations
- Analyst sentiment on Kimberly-Clark is cautious, with recent price target reductions and hold ratings reflecting growth uncertainties.
- The company’s stock has shown modest or negative price performance over the past year, hinting at challenges in boosting investor returns.
- Kimberly-Clark faces competitive pressures in commoditised product categories, which could constrain margin expansion and sales growth.
3M (MMM) Next Earnings Date
3M (MMM) is expected to report its next earnings on July 27, 2026. This release should cover Q2 2026 results, based on the company’s projected earnings calendar. Some market data services had earlier estimated July 17, 2026, but the more recent projected calendar points to July 27, 2026.
Kimberly-Clark (KMB) Next Earnings Date
Kimberly-Clark’s next earnings release is typically expected in late July to early August 2026, with current estimates clustering around July 28, 2026 to August 7, 2026. The report will cover Q2 2026 results, based on the company’s quarterly reporting cycle following its Q1 2026 release in late April. If the company has not formally confirmed a date, the most defensible expectation is an announcement in the final week of July or first week of August.
3M (MMM) Next Earnings Date
3M (MMM) is expected to report its next earnings on July 27, 2026. This release should cover Q2 2026 results, based on the company’s projected earnings calendar. Some market data services had earlier estimated July 17, 2026, but the more recent projected calendar points to July 27, 2026.
Kimberly-Clark (KMB) Next Earnings Date
Kimberly-Clark’s next earnings release is typically expected in late July to early August 2026, with current estimates clustering around July 28, 2026 to August 7, 2026. The report will cover Q2 2026 results, based on the company’s quarterly reporting cycle following its Q1 2026 release in late April. If the company has not formally confirmed a date, the most defensible expectation is an announcement in the final week of July or first week of August.
Buy MMM or KMB in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
